{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Liu J"],"funding":["Ningxia Key Research and Invention Program of Science and Technology Cooperation of the East and the West"],"pagination":["7319563"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9107056"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["2022"],"pubmed_abstract":["As a traditional Chinese medicine formula, Mi-Jian-Chang-Pu decoction (MJCPD) has been successfully used in patients with language dysfunction and hemiplegia after ischemic stroke (IS). Given the excellent protective effects of MJCPD against nerve damage caused by IS in clinical settings, the present investigation mainly focused on its underlying mechanism on ischemia-reperfusion (IR) injury. Firstly, by applying the MCAO-induced cerebral IR injury rats, the efficacy of MJCPD on IS was estimated using the neurological deficit score, TTC, HE, and IHC staining, and neurochemical measurements. Secondly, an UHPLC-QTOF-MS/MS-based nontargeted metabolomics was developed to elucidate the characteristic metabolites. MJCPD groups showed significant improvements in the neurological score, infarction"],"journal":["Oxidative medicine and cellular longevity"],"pubmed_title":["Potential Therapeutic Effects of Mi-Jian-Chang-Pu Decoction on Neurochemical and Metabolic Changes of Cerebral Ischemia-Reperfusion Injury in Rats."],"pmcid":["PMC9107056"],"funding_grant_id":["2017BY079","2017BY084","2019AAC03084","81860753","2018BHF2001","81560684"],"pubmed_authors":["Liu J","Su C","Yang L","Chen J","Ma X","Wang Y","Ren R","Niu Y"],"additional_accession":[]},"is_claimable":false,"name":"Potential Therapeutic Effects of Mi-Jian-Chang-Pu Decoction on Neurochemical and Metabolic Changes of Cerebral Ischemia-Reperfusion Injury in Rats.","description":"As a traditional Chinese medicine formula, Mi-Jian-Chang-Pu decoction (MJCPD) has been successfully used in patients with language dysfunction and hemiplegia after ischemic stroke (IS). Given the excellent protective effects of MJCPD against nerve damage caused by IS in clinical settings, the present investigation mainly focused on its underlying mechanism on ischemia-reperfusion (IR) injury. Firstly, by applying the MCAO-induced cerebral IR injury rats, the efficacy of MJCPD on IS was estimated using the neurological deficit score, TTC, HE, and IHC staining, and neurochemical measurements. Secondly, an UHPLC-QTOF-MS/MS-based nontargeted metabolomics was developed to elucidate the characteristic metabolites. MJCPD groups showed significant improvements in the neurological score, infarction","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-04T09:41:19.948Z","creation":"2025-04-04T09:41:19.948Z"},"accession":"S-EPMC9107056","cross_references":{"pubmed":["35578728"],"doi":["10.1155/2022/7319563"]}}